Dianthus Therapeutics

DNTHNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.092 B

$108.92 -0.91%

Close of 7 Aug 2026

Revenue

$2.04M

#3436 by revenue

Earnings

-$162.3M

Loss-making

Shares outstanding

55,934,378

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#51Xenon PharmaceuticalsXENE$6.12B
#52Ptc TherapeuticsPTCT$6.12B
#53Dianthus TherapeuticsDNTH$6.09B
#54Kiniksa Pharmaceuticals InternationalKNSA$5.93B
#55Ligand PharmaceuticalsLGND$5.88B

Where these numbers come from

Share counts and financials for Dianthus Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.